Lifestance Health (LFST) | Stock Overview & Key Data
Lifestance Health Performance Comparison
Stock Range
Today's Range
Low: $5.51
High: $5.72
on August 22, 2025
52 Week Range
Low: $3.74
High: $8.61
on August 1, 2025
on November 7, 2024
All-Time High: $29.81 on July 5, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.2B
EPS
-0.04
P/E Ratio (TTM)
-37.00
Forward P/E
-32.65
P/B Ratio
1.47
PEG Ratio
0.44
Div. Yield
N/A
ROE
-1.11%
Beta
1.133
Debt to Equity
32.18
Financial Highlights
Profitability
Gross Margin
31.40%
Operating Margin
-0.85%
Profit Margin
-1.23%
Returns and Earnings
Return on Assets (TTM)
0.04%
Return on Equity (TTM)
-1.11%
EBITDA
$56.9M
Net Income (TTM)
$-16.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$3.44
Quarterly Revenue Growth (YoY)
10.60%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Lifestance Health LFST | 2.16B Mid-cap | 2.02% | 32.14% | -1.42% | -26.88% | -26.49% | -10.19% | -15.14% | -76.88% |
| HCA Healthcare HCA | 94.59B Large-cap | 2.32% | 15.39% | 7.52% | 26.72% | 36.01% | 4.16% | 97.57% | 197.79% |
| Tenet Healthcare THC | 15.67B Large-cap | 4.35% | 15.09% | 11.26% | 36.44% | 43.35% | 9.10% | 198.82% | 523.05% |
| DaVita DVA | 9.84B Mid-cap | 3.68% | -3.90% | 1.33% | -1.18% | -6.31% | -8.85% | 58.33% | 61.44% |
| Ensign Group ENSG | 9.77B Mid-cap | 3.77% | 26.46% | 19.21% | 33.58% | 29.78% | 16.46% | 98.37% | 194.07% |
| Chemed CHE | 6.62B Mid-cap | 3.13% | 1.36% | -18.24% | -16.11% | -13.05% | -19.80% | -3.27% | -10.18% |
Ownership & Short Interest
Insider Ownership
8.24%
Institutional Ownership
91.57%
Shares Short
7M
Short Ratio
3.10
Short % of Shares Outstanding
8.59%
Average 10-Day Volume
4M
Average 90-Day Volume
3M
Lifestance Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Lifestance Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LFST's 52-week high and low?
- In the last 52 weeks, Lifestance Health reached a high of $8.61 (on November 7, 2024) and a low of $3.74 (on August 1, 2025).
- What is the market cap and P/E ratio for LFST?
- Curious about Lifestance Health's size and valuation? Its market capitalization stands at 2.16B. When it comes to valuation, the P/E ratio (trailing twelve months) is -37.00, and the forward P/E (looking ahead) is -32.65.
- Does LFST pay dividends? If so, what's the yield?
- As for dividends, Lifestance Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Lifestance Health's main competitors or similar companies to consider before investing?
When looking at Lifestance Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA94.59B Healthcare Medical Care Facilities 4.16% 97.57% Tenet Healthcare
THC15.67B Healthcare Medical Care Facilities 9.10% 198.82% DaVita
DVA9.84B Healthcare Medical Care Facilities -8.85% 58.33% Ensign Group
ENSG9.77B Healthcare Medical Care Facilities 16.46% 98.37% Chemed
CHE6.62B Healthcare Medical Care Facilities -19.80% -3.27% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lifestance Health Group Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Lifestance Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -1.11%, the Debt to Equity ratio from the most recent quarter is 32.18, and its Gross Profit Margin stands at 31.40%.
- What is the recent revenue and earnings growth for LFST?
- Looking at Lifestance Health's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.60%, and quarterly earnings saw a YoY growth of N/A.
- How much of LFST stock is held by insiders and institutions?
- Wondering who owns Lifestance Health stock? Company insiders (like executives and directors) hold about 8.24% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 91.57%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.